FDA-Approved Drugs with Potent In Vitro Antiviral Activity against Severe Acute Respiratory Syndrome Coronavirus 2

FDA-Approved Drugs with Potent In Vitro Antiviral Activity against Severe Acute Respiratory Syndrome Coronavirus 2

(1) Background: Drug repositioning is an unconventional drug discovery approach to explore new therapeutic benefits of existing drugs. Currently, it emerges as a rapid avenue to alleviate the COVID-19 pandemic disease. (2) Methods: Herein, we tested the antiviral activity of anti-microbial and anti-...

Full description

Bibliographic Details
Main Authors:	Ahmed Mostafa, Ahmed Kandeil, Yaseen A. M. M. Elshaier, Omnia Kutkat, Yassmin Moatasim, Adel A. Rashad, Mahmoud Shehata, Mokhtar R. Gomaa, Noura Mahrous, Sara H. Mahmoud, Mohamed GabAllah, Hisham Abbas, Ahmed El Taweel, Ahmed E. Kayed, Mina Nabil Kamel, Mohamed El Sayes, Dina B. Mahmoud, Rabeh El-Shesheny, Ghazi Kayali, Mohamed A. Ali
Format:	Article
Language:	English
Published:	MDPI AG 2020-12-01
Series:	Pharmaceuticals
Subjects:	SARS-CoV-2 COVID-19 antiviral virtual screening drug repurposing
Online Access:	https://www.mdpi.com/1424-8247/13/12/443

Similar Items

Highly pathogenic avian influenza virus H5N1 clade 2.3.4.4b in wild rats in Egypt during 2023
by: Omnia Kutkat, et al.
Published: (2024-12-01)

Emergence of a novel reassortant highly pathogenic avian influenza clade 2.3.4.4b A(H5N2) Virus, 2024
by: Rabeh El-Shesheny, et al.
Published: (2025-12-01)

Impact of Individual Viral Gene Segments from Influenza A/H5N8 Virus on the Protective Efficacy of Inactivated Subtype-Specific Influenza Vaccine
by: Yassmin Moatasim, et al.
Published: (2021-03-01)

Potent Antiviral Activity of Vitamin B12 against Severe Acute Respiratory Syndrome Coronavirus 2, Middle East Respiratory Syndrome Coronavirus, and Human Coronavirus 229E
by: Yassmin Moatasim, et al.
Published: (2023-11-01)

Bioactive Polyphenolic Compounds Showing Strong Antiviral Activities against Severe Acute Respiratory Syndrome Coronavirus 2
by: Ahmed Kandeil, et al.
Published: (2021-06-01)

Robust antiviral activity of commonly prescribed antidepressants against emerging coronaviruses: in vitro and in silico drug repurposing studies
by: Omnia Kutkat, et al.
Published: (2022-07-01)

Systematic, active surveillance for Middle East respiratory syndrome coronavirus in camels in Egypt
by: Mohamed A Ali, et al.
Published: (2017-01-01)

In Vitro and In Vivo Antiviral Studies of New Heteroannulated 1,2,3-Triazole Glycosides Targeting the Neuraminidase of Influenza A Viruses
by: Omnia Kutkat, et al.
Published: (2022-03-01)

Insights into Genetic Characteristics and Virological Features of Endemic Avian Influenza A (H9N2) Viruses in Egypt from 2017–2021
by: Mohamed El Sayes, et al.
Published: (2022-07-01)

Transmission dynamics of avian influenza viruses in Egyptian poultry markets
by: Sara H. Mahmoud, et al.
Published: (2024-07-01)

We are underestimating, again, the true burden of H5N1 in humans
by: Mokhtar Gomaa, et al.
Published: (2023-08-01)

Genetic and Antigenic Characteristics of Highly Pathogenic Avian Influenza A(H5N8) Viruses Circulating in Domestic Poultry in Egypt, 2017–2021
by: Ahmed Kandeil, et al.
Published: (2022-03-01)

Correction: El-Shesheny et al. Highly Pathogenic Avian Influenza A(H5N1) Virus Clade 2.3.4.4b in Wild Birds and Live Bird Markets, Egypt. <i>Pathogens</i> 2023, <i>12</i>, 36
by: Rabeh El-Shesheny, et al.
Published: (2024-08-01)

Highly Pathogenic Avian Influenza A(H5N1) Virus Clade 2.3.4.4b in Wild Birds and Live Bird Markets, Egypt
by: Rabeh El-Shesheny, et al.
Published: (2022-12-01)

Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine: Preclinical Studies
by: Ahmed Kandeil, et al.
Published: (2021-03-01)

Middle East Respiratory Syndrome Coronavirus (MERS-CoV): State of the Science
by: Ahmed Mostafa, et al.
Published: (2020-07-01)

Middle East respiratory syndrome coronavirus infection in non-camelid domestic mammals
by: Ahmed Kandeil, et al.
Published: (2019-01-01)

Active Surveillance for Avian Influenza Virus, Egypt, 2010–2012
by: Ghazi Kayali, et al.
Published: (2014-04-01)

Development and Evaluation of an Inactivated Influenza A(H5N8) Vaccine
by: Khaled A. Elsharkawy, et al.
Published: (2022-09-01)

Active surveillance and genetic evolution of avian influenza viruses in Egypt, 2016–2018
by: Ahmed Kandeil, et al.
Published: (2019-01-01)

PA from a Recent H9N2 (G1-Like) Avian Influenza A Virus (AIV) Strain Carrying Lysine 367 Confers Altered Replication Efficiency and Pathogenicity to Contemporaneous H5N1 in Mammalian Systems
by: Ahmed Mostafa, et al.
Published: (2020-09-01)

Genomic Diversity and Evolution of Identified SARS-CoV-2 Variants in Iraq
by: Ahmed A. Al-Mankhee, et al.
Published: (2024-11-01)

Evolution of H5-Type Avian Influenza A Virus Towards Mammalian Tropism in Egypt, 2014 to 2015
by: Sara Hussein Mahmoud, et al.
Published: (2019-11-01)

Immunogenicity and effectiveness of a bivalent influenza A/H1N2 vaccine strain against seasonal human influenza A viruses in mice
by: Mina Nabil Kamel, et al.
Published: (2022-11-01)

Global Distribution and Molecular Evolution of Bat Coronaviruses
by: Mohamed El Sayes, et al.
Published: (2024-05-01)

Antiviral activity of water extracts of some medicinal and nutritive plants from the Apiaceae family
by: Mohamed GabAllah, et al.
Published: (2020-04-01)

Isolation and full genome sequencing of two human Astroviruses isolated from children in Cairo, Egypt
by: Ahmed El Taweel, et al.
Published: (2020-02-01)

Design and statistical optimisation of emulsomal nanoparticles for improved anti-SARS-CoV-2 activity of N-(5-nitrothiazol-2-yl)-carboxamido candidates: in vitro and in silico studies
by: Ahmed A. Al-Karmalawy, et al.
Published: (2023-12-01)

Diversity of Astroviruses Circulating in Humans, Bats, and Wild Birds in Egypt
by: Ahmed El Taweel, et al.
Published: (2020-04-01)

Investigating the Potential Anti-SARS-CoV-2 and Anti-MERS-CoV Activities of Yellow Necklacepod among Three Selected Medicinal Plants: Extraction, Isolation, Identification, In Vitro, Modes of Action, and Molecular Docking Studies
by: Howaida I. Abd-Alla, et al.
Published: (2022-11-01)

Bio-guided chemical characterization and nano-formulation studies of selected edible volatile oils with potential antibacterial and anti-SARS-CoV-2 activities
by: Mohamed S. Refaey, et al.
Published: (2023-07-01)

Incidence and neutralizing antibody seroprevalence of influenza B virus in Egypt: Results of a community-based cohort study.
by: Noura M Abo Shama, et al.
Published: (2022-01-01)

Comparison of SARS-Cov-2 omicron variant with the previously identified SARS-Cov-2 variants in Egypt, 2020–2022: insight into SARS-Cov-2 genome evolution and its impact on epidemiology, clinical picture, disease severity, and mortality
by: Amr Kandeel, et al.
Published: (2023-08-01)

Naturally Available Flavonoid Aglycones as Potential Antiviral Drug Candidates against SARS-CoV-2
by: Ahmed A. Al-Karmalawy, et al.
Published: (2021-10-01)

Sinapic Acid Suppresses SARS CoV-2 Replication by Targeting Its Envelope Protein
by: Raha Orfali, et al.
Published: (2021-04-01)

Aurasperone A Inhibits SARS CoV-2 In Vitro: An Integrated In Vitro and In Silico Study
by: Mai H. ElNaggar, et al.
Published: (2022-02-01)

Insight into Genetic Characteristics of Identified SARS-CoV-2 Variants in Egypt from March 2020 to May 2021
by: Wael H. Roshdy, et al.
Published: (2022-07-01)

Continuing Threat of Influenza (H5N1) Virus Circulation in Egypt
by: Myoung-don Oh, et al.
Published: (2011-12-01)

Middle East Respiratory Syndrome Coronavirus (MERS-CoV) in Dromedary Camels in Africa and Middle East
by: Ahmed Kandeil, et al.
Published: (2019-08-01)

Antiviral activity of Humulus lupulus (HOP) aqueous extract against MERS-CoV and SARS-CoV-2: in-vitro and in-silico study
by: Thamer Ahmed Bouback, et al.
Published: (2023-03-01)